Results 201 to 210 of about 94,964 (299)
896 Restrictive valvular heart disease in patients with Parkinson's disease treated with pergolide [PDF]
G VANCAMP+6 more
openalex +1 more source
ABSTRACT A 24‐year‐old male with Marfan syndrome was admitted following an episode of ventricular fibrillation (VF) during exercise. He had previously undergone multiple aortic surgical procedures for symptomatic aortic regurgitation and an ascending aortic false aneurysm.
Shota Tokuno+2 more
wiley +1 more source
ABSTRACT Alcohol septal ablation (ASA) is a minimally invasive treatment option for patients with hypertrophic obstructive cardiomyopathy (HOCM) who remain symptomatic despite medical treatment and are either poor surgical candidates or prefer a less invasive approach.
Vishnu Bharani+3 more
wiley +1 more source
Valvular heart disease and cardiomyopathy in China: epidemiology and current treatments. [PDF]
Hu SS.
europepmc +1 more source
ABSTRACT Background Electrocardiographic parameters have emerged as valuable noninvasive markers for risk stratification in acute coronary syndrome (ACS). Aims This study aimed to evaluate the correlation between R wave peak time (RWPT) and coronary artery disease (CAD) severity, and to assess its prognostic value for in‐hospital major adverse cardiac ...
Jilin Xu+5 more
wiley +1 more source
Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves. [PDF]
Dawwas GK, Lewis JD, Cuker A.
europepmc +1 more source
ABSTRACT Background Limited data is available on long‐term outcomes and valve durability measures of transcatheter aortic valve implantation (TAVI). Aims This study sought to assess clinical and echocardiographic outcomes of high‐risk patients during the early experience of TAVI with a follow‐up period extending beyond 10 years.
Ellen Dietze+14 more
wiley +1 more source
Cardiovascular Risk Factors in Patients with Valvular Heart Disease: A Nationwide Observational Cohort Study. [PDF]
Lu Q+18 more
europepmc +1 more source
ABSTRACT Background The use of procedural anticoagulation during primary percutaneous coronary intervention (PCI) is well established and has been shown to improve clinical outcomes in patients with ST‐segment elevation myocardial infarction (STEMI).
Vinícius Martins Rodrigues Oliveira+11 more
wiley +1 more source
Physical Frailty and the Risk of Degenerative Valvular Heart Disease. [PDF]
Guo X+10 more
europepmc +1 more source